Astrana Health (ASTH) Operating Leases: 2019-2025
Historic Operating Leases for Astrana Health (ASTH) over the last 7 years, with Q3 2025 value amounting to $30.2 million.
- Astrana Health's Operating Leases fell 318.02% to $30.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.2 million, marking a year-over-year decrease of 318.02%. This contributed to the annual value of $30.7 million for FY2024, which is 1552.81% down from last year.
- Latest data reveals that Astrana Health reported Operating Leases of $30.2 million as of Q3 2025, which was down 318.02% from $28.7 million recorded in Q2 2025.
- Astrana Health's Operating Leases' 5-year high stood at $42.7 million during Q1 2024, with a 5-year trough of $13.2 million in Q4 2021.
- Its 5-year average for Operating Leases is $24.3 million, with a median of $21.4 million in 2023.
- As far as peak fluctuations go, Astrana Health's Operating Leases skyrocketed by 9965.88% in 2024, and later tumbled by 3220.75% in 2025.
- Over the past 5 years, Astrana Health's Operating Leases (Quarter) stood at $13.2 million in 2021, then surged by 50.89% to $19.9 million in 2022, then soared by 82.22% to $36.3 million in 2023, then decreased by 15.53% to $30.7 million in 2024, then decreased by 1.58% to $30.2 million in 2025.
- Its Operating Leases stands at $30.2 million for Q3 2025, versus $28.7 million for Q2 2025 and $29.0 million for Q1 2025.